80 related articles for article (PubMed ID: 8615187)
1. Dopaminergic regulation of peptide gene expression in the striatum of normal and parkinsonian monkeys.
Parent A; Asselin MC; Côté PY
Adv Neurol; 1996; 69():73-7. PubMed ID: 8615187
[No Abstract] [Full Text] [Related]
2. Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.
Herrero MT; Augood SJ; Hirsch EC; Javoy-Agid F; Luquin MR; Agid Y; Obeso JA; Emson PC
Neuroscience; 1995 Oct; 68(4):1189-98. PubMed ID: 8544992
[TBL] [Abstract][Full Text] [Related]
3. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
[TBL] [Abstract][Full Text] [Related]
4. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
Van De Witte SV; Groenewegen HJ; Voorn P
Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine monkeys.
Bezard E; Ravenscroft P; Gross CE; Crossman AR; Brotchie JM
Neurobiol Dis; 2001 Apr; 8(2):343-50. PubMed ID: 11300729
[TBL] [Abstract][Full Text] [Related]
6. Serotonin 5-HT(1A) receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys.
Frechilla D; Cobreros A; Saldise L; Moratalla R; Insausti R; Luquin M; Del Río J
Synapse; 2001 Mar; 39(4):288-96. PubMed ID: 11169778
[TBL] [Abstract][Full Text] [Related]
7. Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys.
Asselin MC; Soghomonian JJ; Côté PY; Parent A
Neuroreport; 1994 Oct; 5(16):2137-40. PubMed ID: 7865763
[TBL] [Abstract][Full Text] [Related]
8. Expression of striatal preprotachykinin mRNA in symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys is related to parkinsonian motor signs.
Wade TV; Schneider JS
J Neurosci; 2001 Jul; 21(13):4901-7. PubMed ID: 11425917
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human granulocyte colony-stimulating factor protects against MPTP-induced dopaminergic cell death in mice by altering Bcl-2/Bax expression levels.
Cao XQ; Arai H; Ren YR; Oizumi H; Zhang N; Seike S; Furuya T; Yasuda T; Mizuno Y; Mochizuki H
J Neurochem; 2006 Nov; 99(3):861-7. PubMed ID: 17076657
[TBL] [Abstract][Full Text] [Related]
10. The expression of proenkephalin and prodynorphin genes and the induction of c-fos gene by dopaminergic drugs are not altered in the straitum of MPTP-treated mice.
Ziolkowska B; Horn G; Kupsch A; Höllt V
J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):151-64. PubMed ID: 8527000
[TBL] [Abstract][Full Text] [Related]
11. Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.
Graybiel AM; Moratalla R; Quinn B; DeLanney LE; Irwin I; Langston JW
Adv Neurol; 1993; 60():34-9. PubMed ID: 8420148
[No Abstract] [Full Text] [Related]
12. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.
Muñoz A; Rey P; Guerra MJ; Mendez-Alvarez E; Soto-Otero R; Labandeira-Garcia JL
Neuropharmacology; 2006 Jul; 51(1):112-20. PubMed ID: 16678218
[TBL] [Abstract][Full Text] [Related]
13. Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism.
Sagi Y; Mandel S; Amit T; Youdim MB
Neurobiol Dis; 2007 Jan; 25(1):35-44. PubMed ID: 17055733
[TBL] [Abstract][Full Text] [Related]
14. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
Rioux L; Frohna PA; Joyce JN; Schneider JS
Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
[TBL] [Abstract][Full Text] [Related]
15. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
Betarbet R; Greenamyre JT
Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients.
Jan C; François C; Tandé D; Yelnik J; Tremblay L; Agid Y; Hirsch E
Eur J Neurosci; 2000 Dec; 12(12):4525-35. PubMed ID: 11122363
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
18. Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys.
Pope-Coleman A; Tinker JP; Schneider JS
Synapse; 2000 May; 36(2):120-8. PubMed ID: 10767059
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor enhances striatal neuropeptide expression in both the intact and the dopamine-depleted rat striatum.
Sauer H; Campbell K; Wiegand SJ; Lindsay RM; Björklund A
Neuroreport; 1994 Jan; 5(5):609-12. PubMed ID: 8025254
[TBL] [Abstract][Full Text] [Related]
20. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
